This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Stéphane Roche, PhD
Founder and CEO at AdaptBio Therapeutics
Speaker

Profile

Stéphane is the founder and CEO of AdaptBio Therapeutics (Est. in 2024). He has 15+ years of experience in synthetic and medicinal chemistry in diverse therapeutic areas, working on small-molecule natural products and peptide drugs. Stéphane is also a faculty at Florida Atlantic University, where he works on a variety of peptide drug discovery and preclinical development programs focusing on protein-protein interactions. Stéphane received a Ph.D. in Organic Chemistry from the Blaise Pascal University (France) and conducted post-doctoral studies at the @Star ICES Institute (Singapore) and at Boston University in the field of natural product total synthesis.

Agenda Sessions

  • ADAPT: An Emerging Platform of Antibody CDR-H3 Peptide Scaffolds in the Landscape of Protein-Protein Interaction Inhibitors

    11:45am